Abstract
Salmonella spp. are well-recognized foal pathogens. However, prevention of neonatal salmonellosis by vaccinating pregnant mares has not been reported previously. A formalinized adjuvanted bacterin of Salmonella enterica, serovar typhimurium (S typhimurium) and serovar newport (S newport), was given to pregnant mares to determine its safety (study 1) and potency in enhancing Salmonella-specific antibody for colostral transfer to foals (study 2). Antibody levels to S typhimurium (lysate and lipopolysaccharide [LPS]) and S newport (lysate) were determined by enzyme-linked immunoassay and reported as optical density measures. The mares in study 1 (n = 16) exhibited minimal reactions to the bacterin, and pregnancy was maintained in all mares throughout the study period. In study 2, serum antibody levels to both S typhimurium and S newport increased significantly in vaccinated mares (mean OD increase: 0.83 ± 0.58 [lysate of S typhimurium], 1.27 ± 0.82 [LPS of S typhimurium], and 0.67 ± 0.74 [lysate of S newport], respectively; n = 28). Elevated serum antibody levels on day 28 correlated with high antibody levels in colostrum (r2 = 0.62-0.75; P < .0001) and in serum samples of foals (r2 = 0.5-0.73; P < .001).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
